Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Clinical trial NCT06291103 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06291103
- Sponsor
- University Hospital, Rouen
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2032-08-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.